These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28468583)

  • 21. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
    Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and clinical significance of miR-4516 and miR-21-5p in serum of patients with colorectal cancer.
    Jin XH; Lu S; Wang AF
    BMC Cancer; 2020 Mar; 20(1):241. PubMed ID: 32293319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer.
    Wang W; Qu A; Liu W; Liu Y; Zheng G; Du L; Zhang X; Yang Y; Wang C; Chen X
    Eur J Cancer Care (Engl); 2017 Jul; 26(4):. PubMed ID: 26898324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
    Sun J; Song K; Feng X; Gao S
    Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer.
    Hao JP; Ma A
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8649-8656. PubMed ID: 30575905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum
    Wang N; Zeng L; Li Z; Zhen Y; Chen H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
    Wang Y; Yuan W; Ma X; Ma J
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer.
    Wang N; Liu W
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):412-416. PubMed ID: 29424898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
    Zhou T; Zhang G; Liu Z; Xia S; Tian H
    Int J Colorectal Dis; 2013 Jan; 28(1):19-24. PubMed ID: 22772712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
    Tong F; Ying Y; Pan H; Zhao W; Li H; Zhan X
    Bosn J Basic Med Sci; 2018 Aug; 18(3):252-259. PubMed ID: 29338680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
    Cui Y; Xue Y; Dong S; Zhang P
    J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
    Shi Y; Liu Z
    J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer.
    Zeng Z; Chen X; Zhu D; Luo Z; Yang M
    Yonsei Med J; 2017 Jul; 58(4):697-702. PubMed ID: 28540980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum microRNA-135a downregulation as a prognostic marker of non-small cell lung cancer.
    Zhang YK; Sun B; Sui G
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.
    Yu H; Gao G; Jiang L; Guo L; Lin M; Jiao X; Jia W; Huang J
    Int J Clin Exp Pathol; 2013; 6(12):2904-11. PubMed ID: 24294377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer.
    Liu M; Zhi Q; Wang W; Zhang Q; Fang T; Ma Q
    Biomed Pharmacother; 2015 Feb; 69():214-20. PubMed ID: 25661360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.